<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xml:lang="en" article-type="research-article" dtd-version="1.4"><!--The publisher of this article does not allow downloading of the full text in XML form.--><front><journal-meta><journal-id journal-id-type="nlm-ta">J Subst Use Addict Treat</journal-id><journal-id journal-id-type="iso-abbrev">J Subst Use Addict Treat</journal-id><journal-id journal-id-type="pmc-domain-id">319</journal-id><journal-id journal-id-type="pmc-domain">nihpa</journal-id><journal-title-group><journal-title>Journal of substance use and addiction treatment</journal-title></journal-title-group><issn pub-type="ppub">2949-8767</issn><issn pub-type="epub">2949-8759</issn><custom-meta-group><custom-meta><meta-name>pmc-is-collection-domain</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-collection-title</meta-name><meta-value>NIHPA Author Manuscripts</meta-value></custom-meta></custom-meta-group></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC11203204</article-id><article-id pub-id-type="pmcid-ver">PMC11203204.319</article-id><article-id pub-id-type="pmcaid">11203204</article-id><article-id pub-id-type="pmcaiid">11203204</article-id><article-id pub-id-type="manuscript-id">NIHMS1997633</article-id><article-id pub-id-type="pmid">38641055</article-id><article-id pub-id-type="doi">10.1016/j.josat.2024.209363</article-id><article-id pub-id-type="manuscript-id-alternative">NIHMS1997633</article-id><article-id pub-id-type="manuscript-id-alternative">NIHPA1997633</article-id><article-version article-version-type="pmc-version">319</article-version><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Composition of buprenorphine prescribing networks in Medicaid and association with quality of care</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Zhu</surname><given-names initials="JM">Jane M.</given-names></name><degrees>MD, MPP</degrees><xref rid="A1" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Charlesworth</surname><given-names initials="C">Christina</given-names></name><degrees>MPH</degrees><xref rid="A2" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Stein</surname><given-names initials="B">Bradley</given-names></name><degrees>MD, PhD</degrees><xref rid="A3" ref-type="aff">3</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Drake</surname><given-names initials="C">Coleman</given-names></name><degrees>PhD</degrees><xref rid="A4" ref-type="aff">4</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Polsky</surname><given-names initials="D">Daniel</given-names></name><degrees>PhD</degrees><xref rid="A5" ref-type="aff">5</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Korthuis</surname><given-names initials="T">Todd</given-names></name><degrees>MD</degrees><xref rid="A1" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>McConnell</surname><given-names initials="KJ">K. John</given-names></name><degrees>PhD</degrees><xref rid="A2" ref-type="aff">2</xref></contrib></contrib-group><aff id="A1"><label>1</label>Division of General Internal Medicine, Oregon Health &amp; Science University, Portland, Oregon, USA</aff><aff id="A2"><label>2</label>Center for Health Systems Effectiveness, Oregon Health &amp; Science University, Portland, Oregon, USA</aff><aff id="A3"><label>3</label>RAND Corporation, Pittsburgh, Pennsylvania, USA</aff><aff id="A4"><label>4</label>Department of Health Policy and Management, University of Pittsburgh School of Public Health, Pittsburgh, Pennsylvania, USA</aff><aff id="A5"><label>5</label>Department of Health Policy and Management, Bloomberg School of Public Health, Johns Hopkins University</aff><author-notes><corresp id="CR1">Corresponding author: Jane M. Zhu, MD, MPP, 3181 SW Sam Jackson Pk Rd, <email>zhujan@ohsu.edu</email></corresp></author-notes><pub-date pub-type="ppub"><month>8</month><year>2024</year></pub-date><pub-date pub-type="epub"><day>18</day><month>4</month><year>2024</year></pub-date><volume>163</volume><issue-id pub-id-type="pmc-issue-id">465436</issue-id><fpage>209363</fpage><lpage>209363</lpage><pub-history><event event-type="nihms-submitted"><date><day>16</day><month>06</month><year>2024</year></date></event><event event-type="pmc-release"><date><day>01</day><month>08</month><year>2025</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2024-06-27 12:25:13.960"><day>27</day><month>06</month><year>2024</year></date></event></pub-history><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="nihms-1997633.pdf"/><abstract id="ABS1"><sec id="S1"><title>Introduction</title><p id="P1">Despite Medicaid&#8217;s outsized role in delivering and financing medications for opioid use disorder (MOUD), little is known about the extent to which buprenorphine prescriber networks vary across Medicaid health plans, and whether network characteristics affect quality of treatment received. In this observational cross-sectional study, we used 2018&#8211;2019 Medicaid claims in Oregon to assess network variation in the numbers and types of buprenorphine prescribers, as well as the association of prescriber and network characteristics with quality of care.</p></sec><sec id="S2"><title>Methods</title><p id="P2">We describe prescribers (MD/DOs and advanced practice providers) of OUD-approved buprenorphine formulations to patients with an OUD diagnosis, across networks. For each patient who initiated buprenorphine treatment during 2018, we assigned a &#8220;usual prescriber&#8221; and assessed four measures of quality in the 180d following initiation: 1) continuous receipt of buprenorphine; 2) receipt of any behavioral health counseling services; 3) receipt of any urine drug screen; and 4) receipt of any prescription for a benzodiazepine. We used multivariable linear regressions to examine the association of prescriber and network characteristics with quality of buprenorphine care following initiation.</p></sec><sec id="S3"><title>Results</title><p id="P3">We identified 645 providers who prescribed buprenorphine to 20,739 eligible Medicaid enrollees with an OUD diagnosis. The composition of buprenorphine prescriber networks varied in terms of licensing type, specialty, and panel size, with the majority of prescribers providing buprenorphine to small panels of patients. In the 180 days following initiation, a third of patients were maintained on buprenorphine; 69.9% received behavioral health counseling; 88.4% had a urine drug screen; and 11.3% received a benzodiazepine prescription. In regression analyses, while no single network characteristic was associated with higher quality across all examined measures, each one unit increase in prescriber-to-enrollee ratio was associated with a 1.18 p.p. increase in the probability of continuous buprenorphine maintenance during the 180 days following initiation (95% confidence interval=[0.21, 2.15], p = 0.017).</p></sec><sec id="S4"><title>Conclusions</title><p id="P4">Medicaid plans may be able to leverage their networks to provide higher quality care. Our findings, which should be interpreted as descriptive only, suggest that higher prescriber-to-enrollee ratio is associated with increased buprenorphine maintenance. Future research should focus on isolating the causal relationships between MOUD prescribing network design and patient outcomes</p></sec></abstract><kwd-group><kwd>buprenorphine</kwd><kwd>OUD</kwd><kwd>provider networks</kwd><kwd>Medicaid</kwd><kwd>access to care</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>pmc-exception-type</meta-name><meta-value>EMBARGO</meta-value></custom-meta><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>4</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>no</meta-value></custom-meta></custom-meta-group></article-meta></front></article></pmc-articleset>